IMNM

NASDAQ 已收盘

Immunome

16.61 USD
▼-0.17-1.01%
盘后 16.40 -1.26%
2026-11-19
市值
$1.85B
市盈率
—
EPS
-2.60
股息率
—
52 周区间
16.41 – 30.06
成交量
881.28K
Beta
2.66
目标价
35.13
52W 低 16.4152W 高 30.06
价格走势

公司简介

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. It is also developing preclinical assets, including I...